Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Clinical trial NCT01908192 · TERMINATED
Trial details
- NCT number
- NCT01908192
- Sponsor
- SyneuRx International (Taiwan) Corp
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2023-10-26
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.